Med Chem Res
Lotti VJ, Cerino DJ, Chen TB, Kling PJ, Kunkel KA, Springer
JP, Hirshfield J (1988) Methods for drug discovery: development
of potent, selective, orally effective cholecystokinin antagonists.
J Med Chem 31:2235–2246
was dried with anhydrous sodium sulfate and evaporated
under vaccuo. The crude product, thus obtained was sub-
jected to purification through column chromatography on
silica gel (100–200 mesh size) using 25 % ethyl acetate in
petroleum ether as eluent to yield product. The structures
of all products were established on the basis of spectral
Galliford CV, Scheidt KA (2007) Pyrrolidinyl-spirooxindole natural
products as inspiration for the development of potential thera-
Haimov A, Neumann R (2002) Polyethylene glycol as a non-ionic
liquid solvent for polyoxometalate catalyzed aerobic oxidation.
1
analysis (IR, H NMR, 13C NMR, and elemental analysis)
and melting point determination.
Hansch C, Steward AR, Iwasa J, Deutsh EW (1965) The use of a
hydrophobic bonding constant for structure–activity correlations.
Synthesis of spirooxaindoles
Jain SC, Kumar R, Goswami R, Pandey MK, Khurana S, Rohtagi L,
Gyanda K (2005) Synthesis of novel non-isoprenoid phenolic
acids and 3-alkylpyridines. Pure Appl Chem 77:185–193. doi:
Joshi KC, Jain R, Sharma K (1988) J Indian Chem Soc 115:202
Kang T-H, Matsumoto K, Murakami Y, Takayama H, Kitajima M,
Aimi N, Watanabe H (2002) Pteropodine and isopteropodine
positively modulate the function of rat muscarinic M(1) and
5-HT(2) receptors expressed in Xenopus oocyte. Eur J Pharmacol
444:39–45
Kauzmann W (1959) Some factors in the interpretation of protein
denaturation. Adv Protein Chem 14:37
Kidwai M, Jain A, Bhardwaj S (2012a) Magnetic nanoparticles
catalyzed synthesis of diverse N-heterocycles. Mol Divers
In a 50 ml round bottom flask, appropriate active methy-
lene compound (0.01 mol), isatin/bromo isatin/N-alkyl
isatin (0.01 mol), and malononitrile (0.01 mol) in 3 ml
water. To this, iodine (10 mol%) was added, mixed, and
stirred at 40 °C. The progress of reaction was monitored by
TLC. The reaction mixture was treated with aqueous
Na2S2O3 solution. The solid product separated out was
filtered, then washed with water and dried. The crude
product thus obtained was subjected to purification by
column chromatography on silica gel (60–120 mesh size)
using ethylacetate in petroleum ether (10:90) as eluent to
yield pure product. The structures of all products were
1
Kidwai M, Jain A, Sharma A, Kuhad RC (2012b) First time reported
enzymatic synthesis of new series of quinoxalines—A green
established on the basis of spectral analysis (IR, H NMR,
13C NMR, and elemental analysis) and melting point
determination.
Konkoy CS, Fick DB, Cai SX, Lan NC, Keana JFW (2000) PCT Int.
Appl.WO0075123. Chem Abstr 2001(134):29313a
Kubo I, Muroi H, Himejima M (1993) Structure–antibacterial activity
Acknowledgments Author (A. Jain) is thankful to UGC for pro-
viding senior research fellowship. M. Kidwai is grateful to the Uni-
versity of Delhi for providing financial assistance.
relationships of anarcadic acids.
41:1016–1019
J Agric Food Chem
Kulkarni SK, Kaul PN (1980) Substances of marine origin affecting
pentobarbital pharmacokinetics. Indian J Exp Biol 13:270–
272
Leitner W (2002) Supercritical carbon dioxide as a green reaction
medium for catalysis. Acc Chem Res 35:746–756. doi:10.1021/
Marina O, Shibinskaya SA, Lyakhov AV, Mazepa SA, Andronati AV,
Turov NM, Zholobak NYS (2010) Synthesis, cytotoxicity,
antiviral activity and interferon inducing ability of 6-(2-amino-
References
Bonsignore L, Loy G, Secci D, Calignano A (1993) Synthesis and
pharmacological activity of 2-oxo(2H)1-benzopyran-3-carbox-
amide derivatives. Eur J Med Chem 28:517–520
Chandrasekhar S, Narsihmulu C, Sultana SS, Reddy NR (2002)
Poly(ethylene glycol) (PEG) as a reusable solvent medium for
organic synthesis. Application in the Heck reaction. Org Lett
Cornils B, Herrmann WA (1998) Aqueous phase organometallic
catalysis—concepts and applications. Wiley-VCH, Weinheim
Cui CB, Kakeya H, Osada H (1996a) Spirotryprostatin B, a novel
mammalian cell cycle inhibitor produced by Aspergillus fumig-
atus. J Antibiot 49:832
ethyl)-6H-indolo[2,3-b]quinoxalines. Eur
J
Med Chem
Nandakumar A, Thirumurugan P, Perumal PT, Vembu P, Ponnusw-
amy MN, Ramesh P (2010) One-pot multicomponent synthesis
and anti-microbial evaluation of 20-(indol-3-yl)-2-oxospiro(ind-
oline-3,40-pyran) derivatives. Bioorg Med Chem Lett
Patchett AA, Nargund RP (2000) Section IV. Topics in drug design
and discovery. Annu Rep Med Chem 35:289–298. doi:0065-
Penning TD, Talley JJ, Bertanshaw SR, Carter JS, Collins PW, Docter
S, Graneto MJ, Lee IF, Malecha JW, Miyashiro JM, Roger RS,
Rogier DJ, Yu SS, Anderson GD, Burton EG, Cogburn JN,
Gregory SA, Koboldt CM, Perkins EW, Seibert K, Veenbuizen
AW, Zhang YY, Isakson PC (1997) Synthesis and biological
evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2
inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoro-
methyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, cele-
coxib). J Med Chem 40:1347–1365
Cui CB, Kakeya H, Osada H (1996b) Novel mammalian cell cycle
inhibitors, tryprostatins A,
B and other diketopiperazines
produced by Aspergillus fumigatus. II. Physico-chemical prop-
erties and structures. J Antibiot 49:534–540
DeSimone RW, Mitchell KS, Currie SA, Darrow JW, Pippin DA
(2004) Privileged structures: applications in drug discovery.
Comb Chem High Throughput Screen 7:473–493
Elguero J, Goya P, Jagerovic N, Silva AMS (2002) Pyrazoles as
drugs: facts and fantasies. Targets Heterocycl Syst 6:52–98
Evans BE, Rittle KE, Bock MG, DiPardo RM, Freidinger RM,
Whitter WL, Lundell GF, Veber DF, Anderson PS, Chang RSL,
123